Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$240,731.00
Aug 1, 2020
Individual or sole proprietorship
COVID-19 Legal Frameworks for Vaccination Research Rapid Response
157350
The purpose of this funding opportunity is to better understand the laws and regulations for vaccination that exist across Canada in order to determine whether they support or impede the achievement of vaccination program goals and objectives in both routine and emergency contexts, including the current COVID-19 pandemic. In addition, the study will examine the specific issues of mandatory vaccination and compensation for serious events following vaccination, which are of particular relevance for potential COVID-19 vaccine(s).
The proposal will address all of the following objectives:
•Survey at least 7 Canadian provincial and territorial jurisdictions and create a national map of governance frameworks (e.g., key actors, policies, laws, regulations) and any planned or potential changes resulting from COVID-19 vaccination planning.
•Assess provincial and territorial frameworks to facilitate insights into: (a) the commonalities and discrepancies between frameworks; (b) the extent to which, and how, the frameworks address mandates, compensation, and emergency situations; and (c) whether these frameworks encourage health care worker and public trust in vaccination programs and vaccines.
•Undertake the following in relation to the specific issues of mandatory vaccination and compensation for serious adverse events following vaccination, both of which will be essential as potential COVID-19 vaccine(s) are rolled out: (a) a preliminary examination and comparison of how select Canadian frameworks approach these two critical issues; and (b) a preliminary case study of how select Canadian approaches contrast with relevant select foreign jurisdictions.
•Propose areas for consideration for revisions to regulation of vaccination in Canada, including routine and responsive vaccination goals.
$35,000.00
Aug 1, 2020
For-profit organization
YEP - Electrical Engineering & PM
954344
SPR-based label-free device for pre-clinical research in vaccine and therapeutic development.
$80,000.00
Aug 1, 2020
For-profit organization
Cartridge Development for Portable POCT in vaccine and therapeutic development
954651
SPR-based label-free POC device for pre-clinical research in vaccine and therapeutic development.
$415,000,000.00
Jul 22, 2020
For-profit organization
Sanofi FLUZONE® High-Dose Vaccine Facility and Pandemic Preparedness
815915
This project will support the development of a new bulk vaccine manufacturing facility and install state of the art drug product formulation, filling, inspection and packaging (FFIP) capabilities in an existing facility in Toronto, Ontario.
$31,000,000.00
Jul 7, 2020
Academia
000015836
000015836
Accelerate testing of COVID-19 prototype vaccine
$31,000,000.00
Jul 7, 2020
Academia
000015836
000015836
Accelerate testing of COVID-19 prototype vaccine
$31,000,000.00
Jul 7, 2020
Academia
000015836
000015836
Accelerate testing of COVID-19 prototype vaccine
$23,000,000.00
Jul 7, 2020
Academia
000015836
000015836
Accelerate testing of COVID-19 prototype vaccine
$31,000,000.00
Jul 7, 2020
Academia
000015836
000015836
Accelerate testing of COVID-19 prototype vaccine
$31,000,000.00
Jul 7, 2020
Academia
000015836
000015836
Accelerate testing of COVID-19 prototype vaccine